
UP-TO-DATE, RESEARCH BASED INFORMATION ABOUT PSYCHEDELICS.
When the trial ends: The case for post-trial provisions in clinical psychedelic research
We show how conceiving of post-trial provision as an integral site of the research process, and an appropriate destination for research funding, will serve to develop the infrastructure necessary for the post-legalisation psychedelic medicine ecosystem.
History repeating: guidelines to address common problems in psychedelic science
We show how these problems threaten internal validity (treatment effects are due to factors unrelated to the treatment), external validity (lack of generalizability), construct validity (unclear working mechanism), or statistical conclusion validity (conclusions do not follow from the data and methods).
Emerging challenges for psychedelic therapy
We aim to frame these psychedelic research challenges with 4 fundamental questions.
The expanding scope of psychedelics as medicines
I want to give you a peek into the underside of the iceberg of psychedelic research. Let’s step away from the headlines, broaden our scope, and dive into the frontier of this field.
The use of psychedelics in the treatment of medical conditions: An analysis of currently registered psychedelics studies in the American drug trial registry
There appears to be a recent uptrend in registered clinical trials studying psychedelics, which is similar to the recent increase in overall trials registered.
Blossom's psychedelic research recap for January
Researchers in the field of psychedelics hit the ground running at the turn of the new year.
Looking ahead to a psychedelic 2022
2022 looks set to be another busy year for the psychedelics space, with a number of late-stage clinical trials commencing or wrapping
Schedule 1 barriers to research in the UK: An in-depth qualitative analysis
Findings highlight the challenges that Schedule 1 researchers are currently facing and suggest that the government should commission an urgent review
Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern‐era clinical studies.
Therapeutic effects of classic serotonergic psychedelics: A systematic review
How ecstasy and psilocybin are shaking up psychiatry.
ecstasy and psilocybin are shaking up psychiatry